Jianying Liang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jianying Liang has a total of 58 co-authors. Here are the top co-authors by number of shared publications:
- Zhirong Yao
Department of Dermatology, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
6 shared publications Jinxiang Yang
Department of Dermatology, Shanghai Jiao Tong University School of Medicine, Shanghai, China
4 shared publicationsZhirong Yao
Department of Dermatology, Shanghai Jiao Tong University School of Medicine, Shanghai, China
4 shared publications- Jinxiang Yang
Department of Dermatology, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China; Institute of Dermatology, Shanghai Jiaotong University School of Medicine, Shanghai, China
3 shared publications Xuanyi Chen
Department of Dermatology, Shanghai Jiao Tong University School of Medicine, Shanghai, China
3 shared publicationsYidong Tan
Department of Dermatology, Shanghai Jiao Tong University School of Medicine, Shanghai, China
3 shared publications
Latest Publications
- Open Access
- 9 May 2026
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 169, 108776
Virus-associated immune dysregulation presenting as facial granulomatous dermatitis in DiGeorge syndrome: A case series
- 9 May 2026
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 169, 108776
Open AccessVirus-associated immune dysregulation presenting as facial granulomatous dermatitis in DiGeorge syndrome: A case series
- Open Access
- 22 July 2025
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 12, 1574656
Case Report: A novel KRT74 variant in an eight-year-old boy with alopecia totalis successfully treated with baricitinib
Alopecia areata is an autoimmune condition characterized by non-scarring hair loss, with genetic factors playing a significant role in disease susceptibility. We report the case of an 8-year-old boy with alopecia totalis harboring a heterozygous KRT74 variant. While his mother and brother share this variant, they do not exhibit alopecia. Immunofluorescence analysis revealed increased phosphorylation of the JAK1-STAT1 pathway and elevated T cell infiltration, predominantly CD4+ T helper cells, in the proband’s scalp. The patient responded favorably to baricitinib treatment (2 mg/day), showing significant hair regrowth within 1 month and continued improvement over 8 months. This case suggests that KRT74 variants may contribute to immune dysregulation in alopecia areata, highlighting the potential role of JAK inhibitors in genetically predisposed alopecia cases.
- 22 July 2025
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 12, 1574656
Open AccessCase Report: A novel KRT74 variant in an eight-year-old boy with alopecia totalis successfully treated with baricitinib
Alopecia areata is an autoimmune condition characterized by non-scarring hair loss, with genetic factors playing a significant role in disease susceptibility. We report the case of an 8-year-old boy with alopecia totalis harboring a heterozygous KRT74 variant. While his mother and brother share this variant, they do not exhibit alopecia. Immunofluorescence analysis revealed increased phosphorylation of the JAK1-STAT1 pathway and elevated T cell infiltration, predominantly CD4+ T helper cells, in the proband’s scalp. The patient responded favorably to baricitinib treatment (2 mg/day), showing significant hair regrowth within 1 month and continued improvement over 8 months. This case suggests that KRT74 variants may contribute to immune dysregulation in alopecia areata, highlighting the potential role of JAK inhibitors in genetically predisposed alopecia cases.
- 25 April 2025
- Published by Elsevier in Clinical Immunology
- Vol. 277, 110494
Exploring TH17-mediated inflammation in epidermolytic ichthyosis: Clinical and mechanistic insight
- 25 April 2025
- Published by Elsevier in Clinical Immunology
- Vol. 277, 110494
Exploring TH17-mediated inflammation in epidermolytic ichthyosis: Clinical and mechanistic insight
- 10 April 2025
- Published by Wiley in Experimental Dermatology
- Vol. 34 (4) , e70097
Clinical Responses and Transcriptomic Analysis of Spesolimab in a Girl With Severe Dermatitis, Multiple Allergies and Metabolic Wasting Syndrome
Severe dermatitis, multiple allergies, and metabolic wasting syndrome (SAM) is a rare inherited disorder caused by biallelic loss‐of‐function mutations in the desmoglein‐1 (DSG1) or desmoplakin (DSP) genes. Previous studies have demonstrated that acitretin and systemic biologics targeting IL‐17, IL‐12/IL‐23, and IL‐4 are effective in treating SAM syndrome. We report the case of an 8‐year‐old girl diagnosed with SAM syndrome who suffered from recurrent rash episodes due to infections and achieved remission with a combination therapy of Spesolimab and acitretin. Comprehensive diagnostic workup, including serum inflammatory factor assays, flow cytometry, skin immunohistochemical staining, and skin RNA sequencing (RNA‐seq), revealed elevated IL‐36G levels in SAM syndrome, which may be associated with the pathogenesis of generalised pustular psoriasis (GPP) through shared IL‐36‐mediated mechanisms. This case highlights the therapeutic potential of targeting the IL‐36 pathway in SAM syndrome and supports the use of skin RNA‐seq for personalised selection of anti‐inflammatory biologics in rare dermatological disorders. This report marks the first clinical application of Spesolimab in SAM syndrome, offering a novel therapeutic approach.
- 10 April 2025
- Published by Wiley in Experimental Dermatology
- Vol. 34 (4) , e70097
Clinical Responses and Transcriptomic Analysis of Spesolimab in a Girl With Severe Dermatitis, Multiple Allergies and Metabolic Wasting Syndrome
Severe dermatitis, multiple allergies, and metabolic wasting syndrome (SAM) is a rare inherited disorder caused by biallelic loss‐of‐function mutations in the desmoglein‐1 (DSG1) or desmoplakin (DSP) genes. Previous studies have demonstrated that acitretin and systemic biologics targeting IL‐17, IL‐12/IL‐23, and IL‐4 are effective in treating SAM syndrome. We report the case of an 8‐year‐old girl diagnosed with SAM syndrome who suffered from recurrent rash episodes due to infections and achieved remission with a combination therapy of Spesolimab and acitretin. Comprehensive diagnostic workup, including serum inflammatory factor assays, flow cytometry, skin immunohistochemical staining, and skin RNA sequencing (RNA‐seq), revealed elevated IL‐36G levels in SAM syndrome, which may be associated with the pathogenesis of generalised pustular psoriasis (GPP) through shared IL‐36‐mediated mechanisms. This case highlights the therapeutic potential of targeting the IL‐36 pathway in SAM syndrome and supports the use of skin RNA‐seq for personalised selection of anti‐inflammatory biologics in rare dermatological disorders. This report marks the first clinical application of Spesolimab in SAM syndrome, offering a novel therapeutic approach.
- Open Access
- 8 April 2025
- Published by Medical Journals Sweden AB in Acta Dermato-Venereologica
- Vol. 105, adv42531
Clinical and Histopathological Characteristics of Buschke–Ollendorff Syndrome: A Case Series
- 8 April 2025
- Published by Medical Journals Sweden AB in Acta Dermato-Venereologica
- Vol. 105, adv42531
Open AccessClinical and Histopathological Characteristics of Buschke–Ollendorff Syndrome: A Case Series
- Open Access
- 1 February 2025
- Published by Taylor & Francis in Clinical, Cosmetic and Investigational Dermatology
- Vol. ume 18, 427-430
Successful Treatment of Facial Multiple Melanocytic Nevus-Like Dark Macules Caused by Severe Acne Vulgaris by a Single Session of Intense Pulsed Light Treatment
Background and Objective: The case report aims to demonstrate the therapeutic effects of a single session of intense pulsed light (IPL) treatment on facial multiple melanocytic nevus-like dark macules induced by severe acne vulgaris. Materials and Methods: A 17-year-old male with acne was assessed as Pillsbury IV according to the Pillsbury classification. After three sessions of photodynamic therapy (PDT), he experienced an increase in number and darkening of facial melanocytic nevus-like dark macules. We attempted to use broadband light (BBL) (SCITON Company, USA) (420nm, 8J, 180ms; 515nm, 13J, 20ms; 560nm, 16J, 24ms; 590nm, 16J, 24ms) therapy to improve post-inflammatory erythema (PIE) and post-inflammatory hyperpigmentation (PIH). Following a baseline assessment, we performed a single session of IPL treatment on the patient and evaluated the changes in melanocytic nevus-like dark macules, PIE, PIH, and sebum secretion through standardized photography. Results: Compared to the baseline, we observed a significant reduction of the patient’s melanocytic nevus-like dark macules and a significant improvement in PIE, PIH, and sebum secretion after a single IPL treatment. Conclusions: This study provides preliminary evidence of the effects of IPL treatment on melanocytic nevi associated with severe acne vulgaris. Further research is warranted to elucidate the underlying mechanisms and promote the wider application of this treatment modality in managing acne sequelae.
- 1 February 2025
- Published by Taylor & Francis in Clinical, Cosmetic and Investigational Dermatology
- Vol. ume 18, 427-430
Open AccessSuccessful Treatment of Facial Multiple Melanocytic Nevus-Like Dark Macules Caused by Severe Acne Vulgaris by a Single Session of Intense Pulsed Light Treatment
Background and Objective: The case report aims to demonstrate the therapeutic effects of a single session of intense pulsed light (IPL) treatment on facial multiple melanocytic nevus-like dark macules induced by severe acne vulgaris. Materials and Methods: A 17-year-old male with acne was assessed as Pillsbury IV according to the Pillsbury classification. After three sessions of photodynamic therapy (PDT), he experienced an increase in number and darkening of facial melanocytic nevus-like dark macules. We attempted to use broadband light (BBL) (SCITON Company, USA) (420nm, 8J, 180ms; 515nm, 13J, 20ms; 560nm, 16J, 24ms; 590nm, 16J, 24ms) therapy to improve post-inflammatory erythema (PIE) and post-inflammatory hyperpigmentation (PIH). Following a baseline assessment, we performed a single session of IPL treatment on the patient and evaluated the changes in melanocytic nevus-like dark macules, PIE, PIH, and sebum secretion through standardized photography. Results: Compared to the baseline, we observed a significant reduction of the patient’s melanocytic nevus-like dark macules and a significant improvement in PIE, PIH, and sebum secretion after a single IPL treatment. Conclusions: This study provides preliminary evidence of the effects of IPL treatment on melanocytic nevi associated with severe acne vulgaris. Further research is warranted to elucidate the underlying mechanisms and promote the wider application of this treatment modality in managing acne sequelae.
- 3 October 2024
- Published by Wiley in The Journal of Dermatology
- Vol. 52 (3) , 520-525
Clinical and genetic insights into ABCA12 variants in three Chinese families with ichthyosis: Genotype–phenotype correlation
Autosomal recessive congenital ichthyosis (ARCI) comprises a series of non‐syndromic ichthyoses. Pathogenic variants in several genes associated with ARCI have so far been identified. Notably, the variants in ABCA12 play a pivotal role in the pathology of ARCI. In this study, we report three Chinese families with compound heterozygous variants in the ABCA12 gene, including two novel variants and four reported variants. Clinical and genetic analyses were conducted to explore the genotype–phenotype correlation among the patients. Immunohistochemistry and transcriptome sequencing were utilized to assess the impact of pathogenic ABCA12 variants on skin homeostasis, revealing decreased levels of ABCA12 and claudin‐1, alongside increased levels of involucrin and S100A8. In conclusion, our findings contribute to updating the genotype–phenotypic correlation and provide additional evidence for the long‐term use of retinoic acid drugs in patients with causative ABCA12 variants.
- 3 October 2024
- Published by Wiley in The Journal of Dermatology
- Vol. 52 (3) , 520-525
Clinical and genetic insights into ABCA12 variants in three Chinese families with ichthyosis: Genotype–phenotype correlation
Autosomal recessive congenital ichthyosis (ARCI) comprises a series of non‐syndromic ichthyoses. Pathogenic variants in several genes associated with ARCI have so far been identified. Notably, the variants in ABCA12 play a pivotal role in the pathology of ARCI. In this study, we report three Chinese families with compound heterozygous variants in the ABCA12 gene, including two novel variants and four reported variants. Clinical and genetic analyses were conducted to explore the genotype–phenotype correlation among the patients. Immunohistochemistry and transcriptome sequencing were utilized to assess the impact of pathogenic ABCA12 variants on skin homeostasis, revealing decreased levels of ABCA12 and claudin‐1, alongside increased levels of involucrin and S100A8. In conclusion, our findings contribute to updating the genotype–phenotypic correlation and provide additional evidence for the long‐term use of retinoic acid drugs in patients with causative ABCA12 variants.
- Open Access
- 1 January 2023
- Published by XMLink in Annals of Dermatology
- Vol. 35 (Suppl 1) , S79-S83
Coexistence of Subcutaneous Panniculitis-Like T-Cell Lymphoma and Dermatomyositis in a 12-Year-Old Boy
Wei R, et al. Ann Dermatol. 2023 May;35:e49. https://doi.org/10.5021/ad.20.310
- 1 January 2023
- Published by XMLink in Annals of Dermatology
- Vol. 35 (Suppl 1) , S79-S83
Open AccessCoexistence of Subcutaneous Panniculitis-Like T-Cell Lymphoma and Dermatomyositis in a 12-Year-Old Boy
Wei R, et al. Ann Dermatol. 2023 May;35:e49. https://doi.org/10.5021/ad.20.310
- 2 October 2021
- Published by Wiley in The Journal of Dermatology
- Vol. 49 (1) , 161-164
Woolly hair nevus caused by somatic mutation and Costello syndrome caused by germline mutation in HRAS: Consider parental mosaicism in prenatal counseling
Germline mutations in HRAS cause Costello syndrome (CS), while mosaic mutations in HRAS show a variability of phenotypes, ranging from mild features such as keratinocytic epidermal nevus (KEN), sebaceous nevus (SN), woolly hair nevus (WHN) with KEN, to severe manifestations of CS with cutis laxa. We report two individuals. The first was a 2‐year‐old boy with woolly hair nevus (WHN) without any other cutaneous involvement, in whom somatic HRAS mutation (c.34G>A; p.Gly12Ser) was identified in his affected scalp and hair follicle specimens. This is the first reported WHN type 1 (no cutaneous involvement) patient caused by somatic HRAS mutation. The other individual was a 12‐year‐old girl with CS caused by germline HRAS mutation (c.34G>A), that manifested with coarse face, palmoplantar keratoderma, deep palmar and plantar creases, hyperpigmented patches, asymmetry and deformity of lower limbs, atopic dermatitis, as well as mental retardation. Of note, a linear hyperpigmented plaque was observed in her father’s lumbosacral region. Although the father refused to provide semen and skin tissue for further examination, this reminds us of possible mosaicism in parents of individuals with germline de novo HRAS mutation and underlines the importance of parental evaluation for prenatal counseling.
- 2 October 2021
- Published by Wiley in The Journal of Dermatology
- Vol. 49 (1) , 161-164
Woolly hair nevus caused by somatic mutation and Costello syndrome caused by germline mutation in HRAS: Consider parental mosaicism in prenatal counseling
Germline mutations in HRAS cause Costello syndrome (CS), while mosaic mutations in HRAS show a variability of phenotypes, ranging from mild features such as keratinocytic epidermal nevus (KEN), sebaceous nevus (SN), woolly hair nevus (WHN) with KEN, to severe manifestations of CS with cutis laxa. We report two individuals. The first was a 2‐year‐old boy with woolly hair nevus (WHN) without any other cutaneous involvement, in whom somatic HRAS mutation (c.34G>A; p.Gly12Ser) was identified in his affected scalp and hair follicle specimens. This is the first reported WHN type 1 (no cutaneous involvement) patient caused by somatic HRAS mutation. The other individual was a 12‐year‐old girl with CS caused by germline HRAS mutation (c.34G>A), that manifested with coarse face, palmoplantar keratoderma, deep palmar and plantar creases, hyperpigmented patches, asymmetry and deformity of lower limbs, atopic dermatitis, as well as mental retardation. Of note, a linear hyperpigmented plaque was observed in her father’s lumbosacral region. Although the father refused to provide semen and skin tissue for further examination, this reminds us of possible mosaicism in parents of individuals with germline de novo HRAS mutation and underlines the importance of parental evaluation for prenatal counseling.
- 29 July 2019
- Published by Wiley in The Journal of Dermatology
- Vol. 46 (10) , 907-910
Coinheritance of generalized pustular psoriasis and familial Behçet‐like autoinflammatory syndrome with variants in IL36RN and TNFAIP3 in the heterozygous state
Generalized pustular psoriasis (GPP) is now known to be caused by biallelic variants in IL36RN and monoallelic variants in CARD14 and AP1S3. The presence of a modifier locus or oligogenic inheritance have been hypothesized. We report on a patient with a unique coinheritance of pathogenic variants in IL36RN (c.115+6T>C) and TNFAIP3 (c.547C>T, p.R183*) causing the genetic entities GPP and familial Behçet‐like autoinflammatory syndrome (AISBL). The heterozygous variant in IL36RN identified by Sanger sequencing was inherited from his unaffected father, while the heterozygous variant in TNFAIP3 was detected by whole‐exome sequencing and was also identified in the patient's AISBL‐affected maternal relatives. Further functional studies are required to research whether the variant of TNFAIP3 plays a part in the development of GPP or simply causes the Behçet's disease phenotype. However, our data suggest that whole‐exome sequencing for the heterozygous carrier of the IL36RN gene in GPP be used to find the potential second genetic locus.
- 29 July 2019
- Published by Wiley in The Journal of Dermatology
- Vol. 46 (10) , 907-910
Coinheritance of generalized pustular psoriasis and familial Behçet‐like autoinflammatory syndrome with variants in IL36RN and TNFAIP3 in the heterozygous state
Generalized pustular psoriasis (GPP) is now known to be caused by biallelic variants in IL36RN and monoallelic variants in CARD14 and AP1S3. The presence of a modifier locus or oligogenic inheritance have been hypothesized. We report on a patient with a unique coinheritance of pathogenic variants in IL36RN (c.115+6T>C) and TNFAIP3 (c.547C>T, p.R183*) causing the genetic entities GPP and familial Behçet‐like autoinflammatory syndrome (AISBL). The heterozygous variant in IL36RN identified by Sanger sequencing was inherited from his unaffected father, while the heterozygous variant in TNFAIP3 was detected by whole‐exome sequencing and was also identified in the patient's AISBL‐affected maternal relatives. Further functional studies are required to research whether the variant of TNFAIP3 plays a part in the development of GPP or simply causes the Behçet's disease phenotype. However, our data suggest that whole‐exome sequencing for the heterozygous carrier of the IL36RN gene in GPP be used to find the potential second genetic locus.